<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Yestino - The Signal · City Therapeutics</title><link>https://yestino.com/entities/city-therapeutics-5d6755</link><description>Every event involving City Therapeutics</description><language>en</language><atom:link href="https://yestino.com/entities/city-therapeutics-5d6755/feed.xml" rel="self" type="application/rss+xml"/><item><title>City Therapeutics is seeking up to $185 million in a U.S. IPO for its gene-silencing drugs</title><link>https://yestino.com/events/city-therapeutics-is-seeking-up-to-185-million-in-a-u-s-ipo-f403a5</link><guid isPermaLink="true">https://yestino.com/events/city-therapeutics-is-seeking-up-to-185-million-in-a-u-s-ipo-f403a5</guid><pubDate>Fri, 09 Oct 2026 12:31:28 GMT</pubDate><description>The Cambridge, Massachusetts company is offering 9.72 million shares at $17 to $19 each and plans to list on Nasdaq under the symbol CTY
Sources: Quartz</description></item></channel></rss>